Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Real-world clinical experience...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Real-world clinical experience of secukinumab in Chinese patients with psoriasis in real-world practice: a 36-week single-center study of 24 patients

Real-world clinical experience of secukinumab in Chinese patients with psoriasis in real-world practice: a 36-week single-center study of 24 patients

Bibliographic Details
Main Authors: Jing Zhang, Chao Ji, Bo Cheng, Shi-Fan Ruan, Tao Liu, Jin-Wen Huang, Li-Shao Guo
Format: Article
Language:English
Published: Wolters Kluwer 2020-12-01
Series:Chinese Medical Journal
Online Access:http://journals.lww.com/10.1097/CM9.0000000000001259
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://journals.lww.com/10.1097/CM9.0000000000001259

Similar Items

  • Real-world investigation of the efficacy and safety of secukinumab for psoriasis treatment in a Chinese population
    by: Jing-Xin Zeng, et al.
    Published: (2021-01-01)
  • Effectiveness of secukinumab in patients with psoriasis and psoriatic arthritis in a Saudi real-world setting
    by: Ibrahim A. Al-Homood, et al.
    Published: (2024-04-01)
  • Secukinumab in the Treatment of Psoriasis: A Narrative Review on Early Treatment and Real-World Evidence
    by: Piergiorgio Malagoli, et al.
    Published: (2024-09-01)
  • Risankizumab Versus Secukinumab: A Real-World Efficacy and Cost per Responder Comparison in Patients With Psoriasis in Italy
    by: Federico Pirro, et al.
    Published: (2025-01-01)
  • Lack of reactivation of tuberculosis in patients with psoriasis treated with secukinumab in a real-world setting of latent tuberculosis infection
    by: Matteo Megna, et al.
    Published: (2022-07-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs